Multiple Myeloma

Thursday, June 17, 2021 12:00pm to 1:00pm

Add to calendar

This presentation by Dan Sherbenou, MD, PhD, will explore how Myeloma Drug Sensitivity Testing and looking at biomarkers of disease response to new and emerging anti-myeloma therapies in bone marrow and peripheral blood may contribute to our understanding of patients' disease and optimize their treatment.  

0 people are interested in this event

CMS Login
University of Colorado Anschutz Medical Campus Powered by the Localist Community Event Platform © All rights reserved